Pfizerpen Powder For Solution For Injection 20000000U Drug Medication Dosage Information
show timeout overlay link

Your Session Is About to Expire

This online session is about to expire due to inactivity. Click Continue to return to page.

  • myWeekly Ad

Pfizerpen: Powder for solution for injection (20000000U)

Also see:
  • Get answers to Frequently Asked Questions (FAQs)
  • Find other class related drugs
  • Find additional patient usage statistics

Visit Drug Summary Page
Drug Image file default-drug-image.png


What is this Medicine?

PENICILLIN G (pen i SILL in G) is a penicillin antibiotic. It is used to treat certain kinds of bacterial infections. It will not work for colds, flu, or other viral infections.

In-Depth Information

Pfizerpen 20,000,000unit Powder for Injection (NOVAPLUS)

NDC: 000490530
  • Prescription Required
  • Not a Controlled Drug
    (CSA Schedule)
  • FDA Approved




FDA approved for the following conditions:
Bacteremia, Pneumonia, Empyema, Anthrax, Meningitis, Pericarditis, Septicemia, Endocarditis, Infectious Arthritis, Neurosyphilis, Syphilis, Necrotizing Ulcerative Gingivitis, Actinomycosis, Botulism, Rat-bite Fever, Gonorrhea, Diphtheria, Listeriosis, Gas Gangrene, Tetanus, Community-acquired Pneumonia

Sometimes used for but not FDA approved for the following conditions:
Leptospirosis, Lyme Disease, Erysipelas, Uveitis, Skin And Skin Structure Infections, Bacterial Infection Prophylaxis, Optic Neuritis

Storage Information
Store unreconstituted product below 86 degrees F
Pfizerpen 20,000,000unit Powder for Injection (NOVAPLUS)

Reported Side Effects for Pfizerpen 20,000,000unit Powder for Injection (NOVAPLUS)

Blood In The Urine Incidence:
<1.0%*
Severity: MODERATE
Onset: DELAYED
Convulsions Incidence:
<1.0%*
Severity: SEVERE
Onset: DELAYED
Anaphylactoid Reactions Incidence:
<1.0%*
Severity: SEVERE
Onset: RAPID
Low Kidney Function Incidence:
<1.0%*
Severity: SEVERE
Onset: DELAYED
Breathing Difficulties Incidence:
<1.0%*
Severity: SEVERE
Onset: RAPID
Eosinophilia Incidence:
<1.0%*
Severity: MODERATE
Onset: DELAYED
Overactive Reflexes Incidence:
<1.0%*
Severity: MODERATE
Onset: DELAYED
Kidney Inflammation Incidence:
<1.0%*
Severity: SEVERE
Onset: DELAYED
Laryngeal Edema Incidence:
<1.0%*
Severity: SEVERE
Onset: RAPID
Vocal Cord Spasm Incidence:
<1.0%*
Severity: SEVERE
Onset: RAPID
Kidney Damage Incidence:
<1.0%*
Severity: SEVERE
Onset: DELAYED
Lyell'S Syndrome Incidence:
<1.0%*
Severity: SEVERE
Onset: DELAYED
Red, Pimple Rash Incidence:
<1.0%*
Severity: SEVERE
Onset: DELAYED
Severe Allergy Incidence:
<1.0%*
Severity: SEVERE
Onset: RAPID
Angioedema Incidence:
<1.0%*
Severity: SEVERE
Onset: RAPID
Coma Incidence:
<1.0%*
Severity: SEVERE
Onset: EARLY
Exfoliative Dermatitis Incidence:
<1.0%*
Severity: SEVERE
Onset: DELAYED
Hemolytic Anemia Incidence:
<1.0%*
Severity: SEVERE
Onset: DELAYED
Low Blood Pressure Incidence:
<1.0%*
Severity: MODERATE
Onset: RAPID
Bleeding Incidence:
<1.0%*
Severity: MODERATE
Onset: EARLY
Stevens-Johnson Syndrome Incidence:
<1.0%*
Severity: SEVERE
Onset: DELAYED
Protein In The Urine Incidence:
<1.0%*
Severity: MODERATE
Onset: DELAYED
Low White Blood Cells Incidence:
<1.0%*
Severity: MODERATE
Onset: DELAYED
Pseudomembranous Colitis Incidence:
1.0-10.0%*
Severity: MODERATE
Onset: DELAYED
Superinfection Incidence:
1.0-10.0%*
Severity: MODERATE
Onset: DELAYED
Serum Sickness Incidence:
2.0-5.0%*
Severity: SEVERE
Onset: DELAYED
Fever Incidence:
2.0-5.0%*
Severity: MILD
Onset: EARLY
Rash With Pustules Incidence:
2.0-5.0%*
Severity: MILD
Onset: EARLY
Feeling Sick Incidence:
2.0-5.0%*
Severity: MILD
Onset: EARLY
Muscle Pain Incidence:
2.0-5.0%*
Severity: MILD
Onset: EARLY
Loose Stools Incidence:
2.0-5.0%*
Severity: MILD
Onset: EARLY
Skin Rash Incidence:
2.0-5.0%*
Severity: MILD
Onset: EARLY
Vomiting Incidence:
2.0-5.0%*
Severity: MILD
Onset: EARLY
Joint Pain Incidence:
2.0-5.0%*
Severity: MILD
Onset: DELAYED
Tongue Discoloration Incidence:
2.0-5.0%*
Severity: MILD
Onset: DELAYED
Hives Incidence:
2.0-5.0%*
Severity: MILD
Onset: RAPID
Upset Stomach Incidence:
2.0-5.0%*
Severity: MILD
Onset: EARLY
*This is an approximate aggregated range of reported side effects from clinical studies performed on this drug. Your experience with this drug may be different.
Pregnancy & Lactation Information
FIRST Trimester

Class B - Animal studies have revealed no evidence of harm to the fetus, however, there are no adequate and well-controlled studies in pregnant women. OR Animal studies have shown an adverse effect, but adequate and well-controlled studies in pregnant women have failed to demonstrate a risk to the fetus in any trimester.

SECOND Trimester

Class B - Animal studies have revealed no evidence of harm to the fetus, however, there are no adequate and well-controlled studies in pregnant women. OR Animal studies have shown an adverse effect, but adequate and well-controlled studies in pregnant women have failed to demonstrate a risk to the fetus in any trimester.

THIRD Trimester

Class B - Animal studies have revealed no evidence of harm to the fetus, however, there are no adequate and well-controlled studies in pregnant women. OR Animal studies have shown an adverse effect, but adequate and well-controlled studies in pregnant women have failed to demonstrate a risk to the fetus in any trimester.

Lactation

Compatible - This drug is generally safe to take by nursing mothers.


Learning More About
Visit the Drug Summary page where you can:
  • Get answers to Frequently Asked Questions (FAQs)
  • Find other class related drugs
  • Find additional patient usage statistics
Learn More
Patient Experiences with Pfizerpen

Be the first to share your experience!

We want to help our customers stay educated about the medications they are taking. Submit your own observations and experiences to benefit others.

Average Scores
Easy to Take 
0 / 5
0 / 5
Works as Intended 
0 / 5
0 / 5
Tolerable 
0 / 5
0 / 5